Zobrazeno 1 - 10
of 1 179
pro vyhledávání: '"Kakuda Tn"'
Autor:
Agarwal K; Institute of Liver Studies, King's College Hospital, London, England. Electronic address: kosh.agarwal@nhs.net., Buti M; Hospital General Universitari Valle Hebron and CIBER-EHD del Instituto Carlos III, Barcelona, Spain., van Bömmel F; Leipzig University Medical Center, Department of Medicine II, Division of Hepatology, Leipzig, Germany., Lampertico P; Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology, Milan, Italy; CRC 'A.M. and A. Migliavacca' Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Janczewska E; Faculty of Health Sciences, Medical University of Silesia, Katowice, Poland., Bourliere M; Hôpital Saint Joseph, Marseille, France., Vanwolleghem T; Antwerp University Hospital, Edegem, Belgium; Viral Hepatitis Research Group, Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium., Lenz O; Janssen Pharmaceutica NV, Beerse, Belgium., Verbinnen T; Janssen Pharmaceutica NV, Beerse, Belgium., Kakuda TN; Janssen Research & Development, LLC, Brisbane, CA, USA., Mayer C; Janssen Research & Development, LLC, Titusville, NJ, USA., Jezorwski J; Janssen Research & Development, LLC, Titusville, NJ, USA., Muenz D; IQVIA, Research Triangle Park, NC, USA., Beumont M; Janssen Pharmaceutica NV, Beerse, Belgium., Kalmeijer R; Janssen Research & Development, LLC, Titusville, NJ, USA., Biermer M; Janssen Pharmaceutica NV, Beerse, Belgium., Lonjon-Domanec I; Janssen Pharmaceutica NV, Beerse, Belgium.
Publikováno v:
Journal of hepatology [J Hepatol] 2024 Sep; Vol. 81 (3), pp. 404-414. Date of Electronic Publication: 2024 Apr 05.
Autor:
Li H; Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China., Niu X; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China., Zhang Y; Phase I Unit of Drug Clinical Trial Center, Tianjin Fifth Central Hospital, Tianjin, China., Zhang D; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China., Zhang Y; Phase I Unit of Drug Clinical Trial Center, Tianjin Fifth Central Hospital, Tianjin, China., Wang L; Clinical Pharmacology and Pharmacometrics, Janssen China Research & Development, Beijing, China., Miao Y; Clinical Development, Janssen China Research & Development, Beijing, China., Jiang Y; Janssen China Research & Development, Shanghai, China., Ji J; Clinical Pharmacology and Pharmacometrics, Janssen China Research & Development, Beijing, China., Chen Q; Clinical Development, Janssen China Research & Development, Beijing, China., Wu X; Janssen China Research & Development, Shanghai, China., Ediage EN; Janssen Pharmaceutica NV, Beerse, Belgium., Kakuda TN; Janssen Research & Development, South San Francisco, California, USA., Biermer M; Janssen Pharmaceutica NV, Beerse, Belgium.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Feb; Vol. 12 (2), pp. 175-180. Date of Electronic Publication: 2022 Nov 22.
Autor:
Kakuda TN; Janssen Research & Development, LLC, Brisbane, California, USA., Halabi A; Clinical Research Services Kiel GmbH, Kiel, Germany., Klein G; APEX GmbH, Munich, Germany., Sanga M; Janssen Research & Development, LLC, Brisbane, California, USA., Guinard-Azadian C; Janssen Pharmaceutica NV, Beerse, Belgium., Kowalik M; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Nedoschinsky K; Janssen Pharmaceutica NV, Beerse, Belgium., Nangosyah J; Janssen Pharmaceutica NV, Beerse, Belgium., Ediage EN; Janssen Pharmaceutica NV, Beerse, Belgium., Hillewaert V; Janssen Pharmaceutica NV, Beerse, Belgium., Verboven P; Janssen Pharmaceutica NV, Beerse, Belgium., Goris I; Janssen Pharmaceutica NV, Beerse, Belgium., Snoeys J; Janssen Pharmaceutica NV, Beerse, Belgium., Palmer M; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Biermer M; Janssen Pharmaceutica NV, Beerse, Belgium.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2023 Jun; Vol. 63 (6), pp. 732-741. Date of Electronic Publication: 2023 Mar 20.
Autor:
Yuen MF; Department of Medicine, Queen Mary Hospital, School of Clinical Medicine, and State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China. Electronic address: mfyuen@hku.hk., Asselah T; Université de Paris-Cité, Department of Hepatology, AP-HP Hôpital Beaujon, Clichy, INSERM UMR1148, France., Jacobson IM; Division of Gastroenterology and Hepatology, New York University Langone Health, New York, NY, USA., Brunetto MR; Hepatology Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, University Hospital of Pisa, Pisa, Italy., Janssen HLA; Toronto Centre for Liver Disease, University Health Network, Toronto, ON, Canada; Erasmus Medical Center, Rotterdam, Netherlands., Takehara T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan., Hou JL; Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China., Kakuda TN; Janssen Research and Development, Brisbane, CA, USA., Lambrecht T; Janssen Pharmaceutica NV, Beerse, Belgium., Beumont M; Janssen Research and Development, Titusville, NJ, USA., Kalmeijer R; Janssen Research and Development, Titusville, NJ, USA., Guinard-Azadian C; Janssen Pharmaceutica NV, Beerse, Belgium., Mayer C; Janssen Research and Development, Titusville, NJ, USA., Jezorwski J; Janssen Research and Development, Titusville, NJ, USA., Verbinnen T; Janssen Pharmaceutica NV, Beerse, Belgium., Lenz O; Janssen Pharmaceutica NV, Beerse, Belgium., Shukla U; Janssen Research and Development, Titusville, NJ, USA., Biermer M; Janssen Pharmaceutica NV, Beerse, Belgium.
Publikováno v:
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2023 Sep; Vol. 8 (9), pp. 790-802. Date of Electronic Publication: 2023 Jul 10.
Autor:
Crauwels, HM1, Kakuda, TN2, Ryan, B2, Zorrilla, C3, Osiyemi, OO4, Yasin, S5, Brown, K6, Verboven, P1, Hillewaert, V1, Baugh, B6
Publikováno v:
HIV Medicine. Oct2016, Vol. 17 Issue 9, p643-652. 10p.
Autor:
Vandenbossche J; Janssen Pharmaceutica NV, Beerse, Belgium., Yogaratnam J; Janssen Research & Development, South San Francisco, California, USA., Hillewaert V; Janssen Pharmaceutica NV, Beerse, Belgium., Rasschaert F; Janssen Pharmaceutica NV, Beerse, Belgium., Talloen W; Janssen Pharmaceutica NV, Beerse, Belgium., Biewenga J; Janssen Pharmaceutica NV, Beerse, Belgium., Snoeys J; Janssen Pharmaceutica NV, Beerse, Belgium., Kakuda TN; Janssen Research & Development, South San Francisco, California, USA., Palmer M; Janssen Research & Development, Spring House, Pennsylvania, USA., Nangosyah J; Janssen Pharmaceutica NV, Beerse, Belgium., Biermer M; Janssen Pharmaceutica NV, Beerse, Belgium.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Dec; Vol. 11 (12), pp. 1419-1429. Date of Electronic Publication: 2022 Sep 05.
Publikováno v:
HIV Medicine. Aug2013, Vol. 14 Issue 7, p421-429. 9p.
Autor:
Brochot, A1, Kakuda, TN2, Van De Casteele, T3, Opsomer, M3, Tomaka, FL2, Vermeulen, A1, Vis, P3,4
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. Aug2015, Vol. 4 Issue 7, p406-414. 9p.
Autor:
Gane E; New Zealand Liver Transplant Unit, University of Auckland, Auckland, New Zealand., Yuen MF; Department of Medicine, 25809The University of Hong Kong, Hong Kong, China., Kakuda TN; 333755Janssen BioPharma Inc, South San Francisco, CA, USA., Ogawa T; 38200Janssen Pharmaceutical KK, Tokyo, Japan., Takahashi Y; 38200Janssen Pharmaceutical KK, Tokyo, Japan., Goeyvaerts N; 50148Janssen Pharmaceutica NV, Beerse, Belgium., Lonjon-Domanec I; Janssen-Cilag, Issy-les-Moulineaux, France., Vaughan T; 17519Arrowhead Pharmaceuticals, Pasadena, CA, USA., Schluep T; 17519Arrowhead Pharmaceuticals, Pasadena, CA, USA., Hamilton J; 17519Arrowhead Pharmaceuticals, Pasadena, CA, USA., Njumbe Ediage E; 50148Janssen Pharmaceutica NV, Beerse, Belgium., Hillewaert V; 50148Janssen Pharmaceutica NV, Beerse, Belgium., Snoeys J; 50148Janssen Pharmaceutica NV, Beerse, Belgium., Lenz O; 50148Janssen Pharmaceutica NV, Beerse, Belgium., Talloen W; 50148Janssen Pharmaceutica NV, Beerse, Belgium., Biermer M; 50148Janssen Pharmaceutica NV, Beerse, Belgium.
Publikováno v:
Antiviral therapy [Antivir Ther] 2022 Jun; Vol. 27 (3), pp. 13596535221093856.
Autor:
Gane EJ; New Zealand Liver Transplant Unit, University of Auckland, Auckland, New Zealand., Schwabe C; Auckland Clinical Studies, Auckland, New Zealand., Berliba E; ARENSIA Exploratory Medicine, Republican Clinical Hospital, Chisinau, Moldova.; State University of Medicine and Pharmacy N. Testemitanu, Chisinau, Moldova., Tangkijvanich P; Center of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Jucov A; ARENSIA Exploratory Medicine, Republican Clinical Hospital, Chisinau, Moldova.; State University of Medicine and Pharmacy N. Testemitanu, Chisinau, Moldova., Ghicavii N; ARENSIA Exploratory Medicine, Republican Clinical Hospital, Chisinau, Moldova., Verbinnen T; Janssen Pharmaceutica, NV, Beerse, Belgium., Lenz O; Janssen Pharmaceutica, NV, Beerse, Belgium., Talloen W; Janssen Pharmaceutica, NV, Beerse, Belgium., Kakuda TN; Janssen BioPharma Inc., South San Francisco, CA, USA., Westland C; Janssen BioPharma Inc., South San Francisco, CA, USA., Patel M; Janssen BioPharma Inc., South San Francisco, CA, USA., Yogaratnam JZ; Janssen BioPharma Inc., South San Francisco, CA, USA., Dragone L; Janssen BioPharma Inc., South San Francisco, CA, USA., Van Remoortere P; Janssen Pharmaceuticals, Titusville, NJ, USA.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Mar 31; Vol. 77 (4), pp. 1102-1110.